71 related articles for article (PubMed ID: 6282762)
21. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
22. Surface antigens associated with human B cell activation.
Jung LK
Immunol Res; 1986; 5(4):249-62. PubMed ID: 3110330
[No Abstract] [Full Text] [Related]
23. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
25. Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line.
Finerty S; Rowe M; Berry PJ; Ranson DL; Mott MG; Gregory CD; Rickinson AB
Br J Cancer; 1986 Sep; 54(3):385-91. PubMed ID: 3019376
[TBL] [Abstract][Full Text] [Related]
26. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
[TBL] [Abstract][Full Text] [Related]
27. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8.
Hudson GS; Farrell PJ; Barrell BG
J Virol; 1985 Feb; 53(2):528-35. PubMed ID: 2982035
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
[TBL] [Abstract][Full Text] [Related]
29. Viruses and cancer risks: outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host.
Rickinson AB; Gregory CD; Young LS
Med Oncol Tumor Pharmacother; 1987; 4(3-4):177-86. PubMed ID: 2831439
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
Calender A; Billaud M; Aubry JP; Banchereau J; Vuillaume M; Lenoir GM
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8060-4. PubMed ID: 2825176
[TBL] [Abstract][Full Text] [Related]
31. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
Rowe M; Rowe DT; Gregory CD; Young LS; Farrell PJ; Rupani H; Rickinson AB
EMBO J; 1987 Sep; 6(9):2743-51. PubMed ID: 2824192
[TBL] [Abstract][Full Text] [Related]
32. Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes.
Wallace LE; Houghton MA; Rickinson AB; Epstein MA; Bradley BA
Immunogenetics; 1985; 21(3):201-14. PubMed ID: 2580783
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.
Birkenbach M; Liebowitz D; Wang F; Sample J; Kieff E
J Virol; 1989 Sep; 63(9):4079-84. PubMed ID: 2548016
[TBL] [Abstract][Full Text] [Related]
34. Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins.
Bettler B; Maier R; Rüegg D; Hofstetter H
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7118-22. PubMed ID: 2476812
[TBL] [Abstract][Full Text] [Related]
35. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
Masucci MG; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G
J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924
[TBL] [Abstract][Full Text] [Related]
36. Analysis of HPV-1 E4 gene expression using epitope-defined antibodies.
Doorbar J; Evans HS; Coneron I; Crawford LV; Gallimore PH
EMBO J; 1988 Mar; 7(3):825-33. PubMed ID: 2456213
[TBL] [Abstract][Full Text] [Related]
37. Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester.
Tötterman TH; Carlsson M; Nilsson K
Clin Exp Immunol; 1988 Jan; 71(1):187-92. PubMed ID: 2450704
[TBL] [Abstract][Full Text] [Related]
38. Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling.
Gordon J; Webb AJ; Guy GR; Walker L
Immunology; 1987 Apr; 60(4):517-21. PubMed ID: 2438206
[TBL] [Abstract][Full Text] [Related]
39. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.
Gordon J; Walker L; Guy G; Brown G; Rowe M; Rickinson A
Immunology; 1986 Aug; 58(4):591-5. PubMed ID: 2426189
[TBL] [Abstract][Full Text] [Related]
40. Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.
Walker L; Guy G; Brown G; Rowe M; Milner AE; Gordon J
Immunology; 1986 Aug; 58(4):583-9. PubMed ID: 2426188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
